Single-chain antibody (scFv) dimers (also known as diabodies) provide a fac
ile route for production of engineered fragments with favorable tumor targe
ting and biodistribution properties in vivo, A scFv was constructed from th
e variable regions of the anti-carcinoembryonic antigen (CEA) monoclonal an
tibody T84.66 using a peptide linker of only eight amino acid residues in o
rder to prevent formation of scFv monomers and produce dimers (diabodies) e
xclusively, The anti-CEA diabody was secreted at high level from E. coil an
d was purified by affinity chromatography, The T84.66/GS8 diabody bound ant
igen bivalently and retained a high apparent affinity for CEA (K-A = 8.19 x
10(10) M-1) as determined by surface plasmon resonance. Targeting properti
es of I-123-labeled T84.66 diabody were evaluated in vivo using athymic mic
e bearing LS174T human colorectal carcinoma xenografts. I-123-labeled anti-
CPA diabodies exhibited rapid targeting of CPA-positive xenografts, reachin
g a maximum uptake level of 13.68 +/- 1.49% injected dose per gram 2 h afte
r administration. Rapid blood clearance resulted in high tumor/blood uptake
ratios; for example, 9.37 at 6 h and 48.69 at 24 h. Using a gamma camera e
quipped with a pinhole collimator, LS174T xenografts of masses 0.12 to 0.48
gm were readily imaged 6 h after injection, Performance of the anti-CPA di
abody (bivalent, 55 kDa) was compared with previously described cognate fra
gments of T84.66, namely the scFv (28 kDa, monovalent) and minibody (scFv-C
(H)3 dimer; bivalent, 80 kDa) by calculation of imaging figures of merit, R
esults show that diabodies labeled with short-lived radionuclides such as I
-123 Or F-18 Should provide useful rapid clinical imaging agents.